Oral co-delivery nanoemulsion of 5-fluorouracil and curcumin for synergistic effects against liver cancer

References

• Freddie B, Jacques F, Isabelle S, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Zheng R, Qu C, Zhang S, et al. Liver cancer incidence and mortality in China: temporal trends and projections to 2030. Chin J Cancer Res. 2018;30(6):571–579.
   PubMed Web of Science ®Google Scholar
• Li C, Li G, Miao R, et al. Primary liver cancer presenting as pyogenic liver abscess: characteristics, diagnosis, and management. J Surg Oncol. 2012;105(7):687–691.
   PubMed Web of Science ®Google Scholar
• Thomas C, Anjana P. Goals and targets for personalized therapy for HCC. Hepatol Int. 2019;13(2):125–137.
   PubMed Web of Science ®Google Scholar
• Jose JGM, Oscar B, Elisa H, et al. Molecular bases of the poor response of liver cancer to chemotherapy. Clin Res Hepatol Gastroenterol. 2018;42(3):182–192.
   PubMed Web of Science ®Google Scholar
• Minghua L, Wenbo B, Jie R, et al. Enhanced synergism of thermo-chemotherapy for liver cancer with magnetothermally responsive nanocarriers. Theranostics. 2018;8(3):693–709.
   PubMed Web of Science ®Google Scholar
• Bian Z, Jin L, Zhang J, et al. LncRNA—UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p. Sci Rep. 2016;6(1):1–12.
   PubMedGoogle Scholar
• Wang L, Lei S, Dong Y, et al. Long-term floating control-released intravesical preparation of 5-fluorouracil for the local treatment of bladder cancer. Drug Dev Ind Pharm. 2017;43(8):43–50.
   Web of Science ®Google Scholar
• Song Y, Lu M, Qiu H, et al. Activation of FOXO3a reverses 5-fluorouracil resistance in human breast cancer cells. Exp Mol Patho. 2018;105(1):57–62.
   PubMed Web of Science ®Google Scholar
• Huang Y, Wei Y, Yang H, et al. A 5-fluorouracil-loaded floating gastroretentive hollow microsphere: development, pharmacokinetic in rabbits, and biodistribution in tumour-bearing mice. Drug Des Devel Ther. 2016;10:997–1008.
   PubMed Web of Science ®Google Scholar
• Cheng M, Gao X, Wang Y, et al. Synthesis of glycyrrhetinic acid-modified chitosan 5-fluorouracil nanoparticles and its inhibition of liver cancer characteristics in vitro and in vivo. Mar Drugs. 2015;11(9):17–36.
   Web of Science ®Google Scholar
• Ranieri G, Marech I, Porcelli M, et al. Complete response in a patient with liver metastases from breast cancer employing hepatic arterial infusion 5-fluorouracil based chemotherapy plus systemic nab-paclitaxel. Oncotarget. 2018;9(8):197–203.
   Google Scholar
• Jaskanwal DS, Jasvinder K, Ryan K, et al. 5-fluorouracil and cardiotoxicity: a review. Ther Adv Med Oncol. 2018;10:1–18.
   Web of Science ®Google Scholar
• Guo P, He Y, Xu T, et al. Co-delivery system of chemotherapy drugs and active ingredients from natural plants: a brief overview of preclinical research for cancer treatment. Expert Opin Drug Deliv. 2020;17(5):665–675.
   PubMed Web of Science ®Google Scholar
• Noushin A, Zahra H, Hamid M, et al. Concentration- dependent effects of curcumin on 5-fluorouracil efficacy in bladder cancer cells. Asian Pac J Cancer Prev. 2017;18(12):225–230.
   PubMedGoogle Scholar
• Yang H, Huang S, Wei Y, et al. Curcumin enhances the anticancer effect of 5-fluorouracil against Gastric cancer through down-regulation of COX-2 and NF- κB signaling pathways. J Cancer. 2017;8(18):697–706.
   Web of Science ®Google Scholar
• He W, Zhu W, Zhang T, et al. Curcumin reverses 5-fluorouracil resistance by promoting human Colon Cancer HCT-8/5-FU cell apoptosis and down-regulating heat shock protein 27 and P-glycoprotein. Chin J Integr Med. 2019;25(6):416–424.
   PubMed Web of Science ®Google Scholar
• Wei Y, Yang P, Cao S, et al. The combination of curcumin and 5-fluorouracil in cancer therapy. Arch Pharm Res. 2018;41(1): 1–13.
   PubMed Web of Science ®Google Scholar
• Carvalho JERD, Milan TV, Ilse MCV, et al. Modulation of the proteasome pathway by nano-curcumin and curcumin in retinal pigment epithelial cells. Ophthalmic Res. 2017;59(2):98–109.
   PubMed Web of Science ®Google Scholar
• Ruan D, Wang W, Lin C, et al. Effects of curcumin on performance, antioxidation, intestinal barrier and mitochondrial function in ducks fed corn contaminated with ochratoxin A. Animal. 2018;13(1):42–52.
   PubMed Web of Science ®Google Scholar
• Li Q, Deng S, Zhou X, et al. Protection of curcumin against streptozocin-induced pancreatic cell destruction in T2D rats. Planta Med. 2020;86(2):113–120.
   PubMed Web of Science ®Google Scholar
• Ajaikumar BK, Devivasha B, Ganesan P, et al. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. Br J Pharmacol. 2017;174(11):25–48.
   Web of Science ®Google Scholar
• Kazuhiro Y, Shusuke T, Preethi R. Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression. Carcinogenesis. 2017;38(10):36–46.
   Web of Science ®Google Scholar
• Wang N, Feng T, Liu X, et al. Curcumin inhibits migration and invasion of non-small cell lung cancer cells through up-regulation of miR-206 and suppression of PI3K/AKT/mTOR signaling pathway. Acta Pharm. 2020;70(3):399–409.
   PubMed Web of Science ®Google Scholar
• Anirudhan TS. Dextran based nanosized carrier for the controlled and targeted delivery of curcumin to liver cancer cells. Int J Biol Macromol. 2016;88:222–235.
   PubMed Web of Science ®Google Scholar
• Wang J, Wang C, Bu G. Curcumin inhibits the growth of liver cancer stem cells through the phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway. Exp Ther Med. 2018;15(4):50–58.
   Web of Science ®Google Scholar
• Ni W, Li Z, Liu Z, et al. Dual-targeting nanoparticles: co-delivery of curcumin and 5-fluorouracil for synergistic treatment of hepatocarcinoma. J Pharm Sci. 2019;108(3): 84–95.
   Web of Science ®Google Scholar
• Vinod BS, Antony J, Nair HH, et al. Mechanistic evaluation of the signaling events regulating curcumin-mediated chemosensitization of breast cancer cells to 5-fluorouracil. Cell Death Dis. 2013;21(4):505–518.
   Google Scholar
• Yang Z, Liu J, Lu Y. Doxorubicin and CD-CUR inclusion complex coloaded in thermosensitive hydrogel PLGA-PEG-PLGA localized administration for osteosarcoma. Int J Oncol. 2020. DOI:10.3892/ijo.2020.5067
   Web of Science ®Google Scholar
• Yunes P, Omid F, Stephen LA. Evidence of curcumin and curcumin analogue effects in skin diseases: a narrative review. J Cell Physiol. 2019;234(2):65–78.
   Web of Science ®Google Scholar
• Sun Y, Zhao D, Wang G, et al. A novel oral prodrug-targeting transporter MCT1: 5-fluorouracil-dicarboxylate monoester conjugates. Asian J Pharm Sci. 2019;14(6):31–39.
   Web of Science ®Google Scholar
• Sari TP, Mann B, Kumar R, et al. Preparation and characterization of nanoemulsion encapsulating curcumin. Food Hydrocoll. 2015;43:40–46.
   Web of Science ®Google Scholar
• Rodríguez-Burneo N, Busquets MA, Estelrich J. Magnetic nanoemulsions: comparison between nanoemulsions formed by ultrasonication and by spontaneous emulsification. Nanomaterials. 2017;7(7):190–203.
   Web of Science ®Google Scholar
• Migotto A, Carvalho V, Salata GC, et al. Multifunctional nanoemulsions for intraductal delivery as a new platform for local treatment of breast cancer. Drug Deliv. 2018;25(1):54–67.
   Web of Science ®Google Scholar
• Kaur A, Katiyar SS, Kushwah V, et al. Nanoemulsion loaded gel for topical Co-delivery of Clobitasol propionate and calcipotriol in psoriasis. Nanomedicine. 2017;13(4):73–82.
   Web of Science ®Google Scholar
• Verma P, Meher JG, Asthana S, et al. Perspectives of nanoemulsion assisted oral delivery of docetaxel for improved chemotherapy of cancer. Drug Deliv. 2014;23(2):79–88.
   PubMed Web of Science ®Google Scholar
• Sung HL, Jason KS, Dong WL, et al. Systematic evaluation of gastric tumour cell index and two-drug combination therapy via 3-dimensional high-throughput drug screening. Front Oncol. 2019;9:27–38.
   PubMed Web of Science ®Google Scholar
• Zhang N, Fu J, Chou T. Synergistic combination of microtubule targeting anticancer fludelone with cytoprotective panaxytriol derived from panax ginseng against MX-1 cells in vitro: experimental design and data analysis using the combination index method. Am J Cancer Res. 2015;6(1):97–104.
   PubMed Web of Science ®Google Scholar
• Wu B, Lu S, Zhang L, et al. Codelivery of doxorubicin and triptolide with reduction-sensitive lipid–polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment. Int J Nanomedicine. 2017;12:53–62.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang H, Hao J, et al. Lung cancer combination therapy: co-delivery of paclitaxel and doxorubicin by nanostructured lipid carriers for synergistic effect. Drug Deliv. 2015;23(4):398–403.
   Web of Science ®Google Scholar
• Yong Z, Wang X, Jie H, et al. Formulation, production, in vitro release and in vivo pharmacokinetics of cinnamaldehyde sub-micron emulsions. Pharm Dev Technol. 2020;16:1–10.
   Google Scholar
• Khalid N, Kobayashi I, Neves MA, et al. Microchannel emulsification: a promising technique towards encapsulation of functional compounds. Crit Rev Food Sci Nutr. 2018;58(14):64–85.
   Web of Science ®Google Scholar
• Powell KC, Damitz R, Chauhan A. Relating emulsion stability to interfacial properties for pharmaceutical emulsions stabilized by Pluronic F68 surfactant. Int J Pharm. 2017;521(1–2):8–18.
   PubMedGoogle Scholar
• Swati J, Prashant M. Co-delivery of curcumin and serratiopeptidase in heLa and MCF-7 cells through nanoparticles show improved anti-cancer activity. Mater Sci Eng C Mater Biol Appl. 2018;92:673–684.
   PubMed Web of Science ®Google Scholar
• Sonvico F, Conti C, Colombo G, et al. Multi-kinetics and site-specific release of gabapentin and flurbiprofen from oral fixed-dose combination: in vitro release and in vivo food effect. J Control Release. 2017;262:296–304.
   PubMed Web of Science ®Google Scholar
• Sauraj VK, Bijender K, Vinay K, et al. Redox responsive xylan-SS-curcumin prodrug nanoparticles for dual drug delivery in cancer therapy. Mater Sci Eng C Mater Biol Appl. 2020;107:110356.
   PubMed Web of Science ®Google Scholar
• Ni W, Li Z, Liu Z, et al. Dual-targeting nanoparticles: codelivery of curcumin and 5-fluorouracil for synergistic treatment of hepatocarcinoma. J Pharm Sci. 2018;108(3):84–95.
   Web of Science ®Google Scholar
• Huang Y, Hu L, Huang S, et al. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration. Int J Nanomedicine. 2018;13:8309–8323.
   PubMed Web of Science ®Google Scholar
• Lin J, Ye Q, Yang Q, et al. Hierarchical bioresponsive nanocarriers for codelivery of curcumin and doxorubicin. Colloids Surf B Biointerfaces. 2019;180:93–101.
   PubMed Web of Science ®Google Scholar
• Naghma K, Farah J, Emily LE, et al. Fisetin and 5-fluorouracil: effective combination for PIK3CA-mutant colorectal cancer. Int J Cancer. 2019;145(11):22–32.
   Web of Science ®Google Scholar
• Ji D, Guan L, Luo X, et al. Inhibition of MALAT1 sensitizes liver cancer cells to 5-flurouracil by regulating apoptosis through IKKα/NF-κB pathway. Biochem Biophys Res Commun. 2018;501(1):33–40.
   Google Scholar
• Vahid S, Amirhossein S, Hossein H. Turmeric (Curcuma Longa) and its major constituent (Curcumin) as nontoxic and safe substances: review. Phytother Res. 2018;32(6):85–95.
   Web of Science ®Google Scholar
• Nusrat B, Rahila N. Histopathological and biochemical assessment of liver damage in albino wistar rats treated with cytotoxic platinum compounds in combination with 5-fluorouracil. Arch Med Sci. 2019;15(4):1092–1103.
   PubMed Web of Science ®Google Scholar
• Jun HC, Arjun KG. Coronary artery vasospasm induced by 5-fluorouracil: proposed mechanisms, existing management options and future directions. Interv Cardiol. 2019;14(2):89–94.
   PubMedGoogle Scholar
• Bee LT, Mohd EN. Curcumin combination chemotherapy: the implication and efficacy in cancer. Molecules. 2019;24(14):1–21.
   Web of Science ®Google Scholar
• Layoun ML, Chanaka DW, Maria VP, et al. Fluoropyrimidine-Induced cardiotoxicity: manifestations, mechanisms, and management. Curr Oncol Rep. 2016;18(6):35–47.
   PubMed Web of Science ®Google Scholar
• Asif N, Tin WW. Chitosan-carboxymethyl-5-fluorouracil-folate conjugate particles: microwave modulated uptake by skin and melanoma cells. J Invest Dermatol. 2018;138(11):12–22.
   Web of Science ®Google Scholar
• Keiko G, Yutaka F, Takeshi I, et al. Pharmacokinetic study of the oral fluorouracil antitumour agent S-1 in patients with impaired renal function. Cancer Sci. 2019;110(6):87–94.
   Web of Science ®Google Scholar
• Takanori T. Curcumin as a functional food-derived factor: degradation products, metabolites, bioactivity, and future perspectives. Food Funct. 2018;9(2):705–714.
   PubMed Web of Science ®Google Scholar
• Panchanan M, Gary LD. Use of curcumin, a natural polyphenol for targeting molecular pathways in treating age-related neurodegenerative diseases. Int J Mol Sci. 2018;19(6):37–79.
   Web of Science ®Google Scholar
• Vanessa TC, Pierre PDK, Yahya EC, et al. Nanotechnology-based biopolymeric oral delivery platforms for advanced cancer treatment. Cancers (Basel). 2020;12(2):22–44.
   Web of Science ®Google Scholar